Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda

BACKGROUND: In May 2018, following the preliminary results of a study in Botswana that reported congenital anomalies in babies born to HIV-positive women taking dolutegravir drug, the WHO issued a teratogenicity alert. However, there are scarce data on the impact of this guidance on contraceptive up...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbabazi, Leah, Nabaggala, Mariah Sarah, Kiwanuka, Suzanne, Kiguli, Juliet, Laker, Eva, Kiconco, Arthur, Okoboi, Stephen, Lamorde, Mohammed, Castelnuovo, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238171/
https://www.ncbi.nlm.nih.gov/pubmed/35761248
http://dx.doi.org/10.1186/s12905-022-01842-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238171/
https://www.ncbi.nlm.nih.gov/pubmed/35761248
http://dx.doi.org/10.1186/s12905-022-01842-7

Ejemplares similares